Table 2 Demographic and clinical characteristics of participants who participated in HPV-based cervical cancer screening by notification method and communities
Variable | First four communities n = 2368 | Last two communities n = 935 | p-value | Standard text group n = 566 | Enhanced text group n = 264 | p-value |
|---|---|---|---|---|---|---|
Age, mean (sd) | 38.6 (11.5) | 37.1 (10.7) | 0.004 | 34.2 (8.7) | 33.1 (7.4) | 0.238 |
Marital status | 0.551 | 0.400 | ||||
Married | 1808 (76.4) | 704 (75.3) | 472 (83.4) | 206 (78.8) | ||
Separated/divorced | 31 (1.3) | 8 (0.9) | 4 (0.7) | 2 (0.8) | ||
Single | 35 (1.5) | 13 (1.4) | 9 (1.6) | 7 (2.7) | ||
Widowed | 494 (20.9) | 210 (22.5) | 81 (14.3) | 47 (17.8) | ||
Education | 0.488 | 0.518 | ||||
None/Some primary | 1475 (62.3) | 573 (61.3) | 190 (33.6) | 101 (38.3) | ||
Completed primary | 536 (22.6) | 198 (21.2) | 180 (31.8) | 81 (30.7) | ||
Some secondary | 166 (7.0) | 74 (7.9) | 85 (15.0) | 30 (11.4) | ||
Completed secondary | 122 (5.2) | 57 (6.1) | 67 (11.8) | 29 (11.0) | ||
College and beyond | 69 (2.9) | 33 (3.5) | 44 (7.8) | 23 (8.7) | ||
Occupation | < 0.001 | < 0.001 | ||||
Unemployed | 250 (10.6) | 79 (8.5) | 64 (11.3) | 21 (8.0) | ||
Business | 884 (37.3) | 576 (61.6) | 218 (38.5) | 155 (58.7) | ||
Farming | 919 (38.8) | 202 (21.6) | 188 (33.2) | 52 (19.7) | ||
Other | 315 (13.3) | 78 (8.3) | 96 (17.0) | 36 (13.6) | ||
Number of children, mean (sd) | 5.0 (2.9) | 4.5 (2.5) | 0.005 | 4.2 (2.4) | 4.0 (2.3) | 0.382 |
Number of children under 13, mean (sd) | 2.0 (1.6) | 2.1 (1.6) | 0.072 | 2.3 (1.5) | 2.3 (1.5) | 0.719 |
Prior cervical cancer screening, n (%) | 305 (12.9) | 193 (20.7) | < 0.001 | 104 (18.4) | 68 (25.8) | 0.015 |
Type of cervical cancer screening received | < 0.001 | 0.023 | ||||
VIA/VILI | 253 (83.2) | 131 (67.9) | 85 (82.5) | 43 (63.2) | ||
Pap smear | 9 (3.0) | 4 (2.1) | 1 (1.0) | 0 | ||
HPV | 38 (12.5) | 52 (26.9) | 15 (14.6) | 22 (32.4) | ||
Don’t know | 4 (1.3) | 6 (3.1) | 2 (1.9) | 3 (4.4) | ||
Prior cervical cancer screening result | 0.239 | 0.187 | ||||
Positive | 5 (1.6) | 8 (4.2) | 2 (1.9) | 3 (4.4) | ||
Negative | 269 (88.2) | 167 (86.5) | 95 (91.4) | 64 (94.1) | ||
Don’t know | 31 (10.2) | 18 (9.3) | 7 (6.7) | 1 (1.5) | ||
Prior cervical cancer treatment | 0.196 | 0.095 | ||||
Yes | 3 (1.0) | 6 (3.1) | 0 | 3 (4.4) | ||
No | 297 (96.7) | 185 (95.4) | 102 (98.1) | 64 (94.1) | ||
Don’t know | 7 (2.3) | 3 (1.6) | 2 (1.9) | 1 (1.47) | ||
Prior HIV testing | 2283 (96.4) | 906 (96.9) | 0.329 | 555 (98.1) | 259 (98.1) | 0.312 |
HIV Status | < 0.001 | < 0.001 | ||||
Positive | 459 (20.3) | 315 (34.9) | 112 (20.2) | 84 (32.6) | ||
Negative | 1806 (79.7) | 587 (65.1) | 443 (79.8) | 174 (67.4) | ||
Currently enrolled in HIV Care | 458 (99.8) | 313 (99.4) | 0.359 | 111 (99.1) | 83 (98.8) | 0.837 |
Family planning | 0.008 | 0.933 | ||||
Yes | 921 (38.9) | 409 (43.7) | 300 (53.1) | 141 (53.4) | ||
No | 1415 (59.8) | 508 (54.3) | 265 (46.9) | 123 (46.6) | ||
Not sexually active | 29 (1.2) | 18 (1.9) | 0 | 0 | ||
Tested positive for HPV through this study | 403 (17.0) | 152 (16.3) | 0.594 | 90 (15.9) | 41 (15.5) | 0.943 |
Completed treatment | 182 (45.2) | 75 (49.3) | 0.378 | 48 (53.3) | 22 (53.7) | 0.928 |